All updated as on -
The global genetic testing market size was valued at USD 7,504.06 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 23.01% from 2023 to 2030.
Market value for cytogenetic testing is expected to reach USD 7656.2 million by 2021, a CAGR of 11.4% from its 2016 value of USD 3086.6 million. The study of chromosomes in living organisms is called cytogenetics. Cancer, sickle cell disease, cystic fibrosis, and Down syndrome are only a few examples of inherited diseases studied by biologists and medical doctors. Cytogenetics paves the way for personalised medicine, localised cancer therapies, and other advancements.
Testing for pharmacogenetic variants is rapidly emerging as an indispensable tool for guiding doctors in the selection of appropriate drugs and dosing for individual patients. The Association for Molecular Pathology (AMP) Pharmacogenomics (PGx) has published a number of publications advocating for the incorporation of clinical pharmacogenomics assays in order to promote uniformity amongst laboratories. The organisation released guidelines for the development and validation of clinical NUDT15 and TPMT genotyping tests in August 2022. The minimum set of alleles recommended by the guidelines for TPMT and NUDT15 genotyping can be used by diagnostic laboratories to identify people at risk for thiopurine poisoning.
The global economy, public healthcare systems, and quality of life were all severely impacted by the COVID-19 pandemic. It is predicted, however, that genetic testing will have a relatively beneficial effect on the expansion rate. For instance, many scientists used genotoxic testing to evaluate anti-COVID-19 medicines. Chloroquine (CQ) and Hydroxychloroquine (HCQ) were studied as potential preventative medications against the virus in a September 2020 study. Research utilising genetic toxicology testing as an assessment tool is expected to underpin sustained expansion in the years following COVID-19.
From 2023 to 2030, the next-generation sequencing market is expected to expand at a CAGR of 23.03%. Reasons for this expansion include more funding for genomic mapping initiatives, rising healthcare costs, improved technology, and more novel uses for next-generation sequencing. Cancers of varying sorts and a variety of genetic abnormalities are increasingly being diagnosed and studied with the use of DNA sequencing technologies. Tumour DNA sequencing allows for the detection of specific DNA changes by genetic testing or profiling. Understanding genetic mutations also aids in developing individualised treatment regimens. Cancer and other genetic illnesses are on the rise, which has increased the need for diagnostic genetic testing in both clinical and research settings.
Report Coverage
Global Genetic Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Genetic Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Genetic Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Genetic Testing market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Genetic Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Genetic Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Genetic Testing market based on the below-mentioned segments:
Global Genetic Testing Market, Technology Outlook
Global Genetic Testing market, By Application
Ancestry & Ethnicity
Traits Screening
Genetic Disease Carrier Status
New Baby Screening
Health and Wellness-Predisposition/Risk/Tendency
Global Genetic Testing Market, By Product Outlook
Consumables
Equipment
Software & Services
Global Genetic Testing Market, By Channel Outlook
Online
Offline
Global Genetic Testing Market, By End-user Outlook
Hospitals & Clinics
Diagnostic Laboratories
Others
Global Genetic Testing market, Regional Analysis
Market value for cytogenetic testing is expected to reach USD 7656.2 million by 2021, a CAGR of 11.4% from its 2016 value of USD 3086.6 million. The study of chromosomes in living organisms is called cytogenetics. Cancer, sickle cell disease, cystic fibrosis, and Down syndrome are only a few examples of inherited diseases studied by biologists and medical doctors. Cytogenetics paves the way for personalised medicine, localised cancer therapies, and other advancements.
Testing for pharmacogenetic variants is rapidly emerging as an indispensable tool for guiding doctors in the selection of appropriate drugs and dosing for individual patients. The Association for Molecular Pathology (AMP) Pharmacogenomics (PGx) has published a number of publications advocating for the incorporation of clinical pharmacogenomics assays in order to promote uniformity amongst laboratories. The organisation released guidelines for the development and validation of clinical NUDT15 and TPMT genotyping tests in August 2022. The minimum set of alleles recommended by the guidelines for TPMT and NUDT15 genotyping can be used by diagnostic laboratories to identify people at risk for thiopurine poisoning.
The global economy, public healthcare systems, and quality of life were all severely impacted by the COVID-19 pandemic. It is predicted, however, that genetic testing will have a relatively beneficial effect on the expansion rate. For instance, many scientists used genotoxic testing to evaluate anti-COVID-19 medicines. Chloroquine (CQ) and Hydroxychloroquine (HCQ) were studied as potential preventative medications against the virus in a September 2020 study. Research utilising genetic toxicology testing as an assessment tool is expected to underpin sustained expansion in the years following COVID-19.
From 2023 to 2030, the next-generation sequencing market is expected to expand at a CAGR of 23.03%. Reasons for this expansion include more funding for genomic mapping initiatives, rising healthcare costs, improved technology, and more novel uses for next-generation sequencing. Cancers of varying sorts and a variety of genetic abnormalities are increasingly being diagnosed and studied with the use of DNA sequencing technologies. Tumour DNA sequencing allows for the detection of specific DNA changes by genetic testing or profiling. Understanding genetic mutations also aids in developing individualised treatment regimens. Cancer and other genetic illnesses are on the rise, which has increased the need for diagnostic genetic testing in both clinical and research settings.
Report Coverage
Global Genetic Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Genetic Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Genetic Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Genetic Testing market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | 24 genetics, Circle DNA, Tellmegen, 23andme, AncestryDNA, MyDNA, Everly Well, Igenomix, VitaGen, Myriad Genetics, Inc., Mapmygenome, Helix OpCo LLC, MyHeritage Ltd., Illumina, Inc., Color Genomics, Inc., Amgen, Inc., Beyond Nutrition Health and Wellness Services DMCC |
| Segments Covered | • By Product • By Application • By Geography |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Genetic Testing Market from 2021 to 2030.
- Market Forecast for Genetic Testing Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Genetic Testing competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Genetic Testing
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Genetic Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Genetic Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
- 24 genetics
- Circle DNA
- Tellmegen
- 23andme
- AncestryDNA
- MyDNA
- Everly Well
- Igenomix
- VitaGen
- Myriad Genetics, Inc.
- Mapmygenome
- Helix OpCo LLC
- MyHeritage Ltd.
- Illumina, Inc.
- Color Genomics, Inc.
- Amgen, Inc.
- Beyond Nutrition Health and Wellness Services DMCC
Primary Target Market
- Market Players of Genetic Testing
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Genetic Testing market based on the below-mentioned segments:
Global Genetic Testing Market, Technology Outlook
- Next Generation Sequencing
- Array Technology
- PCR-based Testing
- FISH
- Others
Global Genetic Testing market, By Application
Ancestry & Ethnicity
Traits Screening
Genetic Disease Carrier Status
New Baby Screening
Health and Wellness-Predisposition/Risk/Tendency
Global Genetic Testing Market, By Product Outlook
Consumables
Equipment
Software & Services
Global Genetic Testing Market, By Channel Outlook
Online
Offline
Global Genetic Testing Market, By End-user Outlook
Hospitals & Clinics
Diagnostic Laboratories
Others
Global Genetic Testing market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive genetic testing market market research and competitor analysis for your business to help you develop more profound insights into the genetic testing market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the genetic testing market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.